Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
48.88B
Market cap48.88B
Price-Earnings ratio
35.86
Price-Earnings ratio35.86
Dividend yield
Dividend yield
Average volume
2.77M
Average volume2.77M
High today
High today
Low today
Low today
Open price
$84.48
Open price$84.48
Volume
0.00
Volume0.00
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $83.58. The company's market cap stands at 48.88B, with a P/E ratio of 35.86.

Edwards Lifesciences(EW) stock opened on 2025-12-12 at $84.48. The price climbed to — and dipped to —.

Edwards Lifesciences(EW) shares are trading with a volume of 0, against a daily average of 2.77M.

During the past year, Edwards Lifesciences(EW) stock moved between $65.94 at its lowest and $87.89 at its peak.

During the past year, Edwards Lifesciences(EW) stock moved between $65.94 at its lowest and $87.89 at its peak.

EW News

TipRanks 10h
Insider Moves: Edwards Lifesciences Stock Sale Unveiled!

New insider activity at Edwards Lifesciences ( (EW) ) has taken place on December 11, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock h...

Nasdaq 23h
Should You Continue to Hold EW Stock in Your Portfolio?

Edwards Lifesciences Corporation EW is well-poised to grow in the coming quarters owing to its Surgical Structural Heart, which pioneered the RESILIA tissue. Th...

Should You Continue to Hold EW Stock in Your Portfolio?
TipRanks 1d
Edwards Lifesciences price target raised to $101 from $96 at Citi

Citi analyst Joanne Wuensch raised the firm’s price target on Edwards Lifesciences (EW) to $101 from $96 and keeps a Buy rating on the shares. The firm adjusted...

Analyst ratings

63%

of 35 ratings
Buy
62.9%
Hold
37.1%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.